News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
PrEP
PrEP...Forever? When Do You Stop Taking PrEP

In his blog on taking pre-exposure prophylaxis, Jake Sobo asks: do we stop taking PrEP if we start a long-term relationship?

Published
17 January 2013
From
Frontiers LA
PrEP
Why we need a pre-exposure prophylaxis (PrEP) trial among gay men in the UK

We need new HIV prevention methods, as 3000 gay men are diagnosed with HIV in the UK each year.

Published
16 January 2013
From
Medical Research Council
PrEP
Research Initiative, Treatment Action (RITA!): Special issue on pre-exposure prophylaxis (PrEP)

The special issue of RITA features two comprehensive reviews of preexposure prophylaxis (PrEP) and interviews with two PrEP experts. Robert Grant (UCSF) strongly argues that healthcare professionals should consider PrEP for anyone who states they want to find new ways to protect themselves or their partners from HIV, regardless of apparent or perceived risk factors.

Published
10 December 2012
From
Center for AIDS
PrEP
The HIV Prevention Pill: How Is Truvada Taking Root in Black Communities?

In the months since the FDA’s approval, some who work on prevention efforts in Black and low-income communities have urged PrEP proponents to pump their brakes. Interviews with advocates, service providers, policy experts, HIV testers, and people living with the virus reveal a range of perspectives. Some committed to fighting the spread of HIV are excited about the pill's new availability as a prevention tool. Others worry about how it’s being rolled out in communities where distrust of medical systems runs high. There’s also a concern that the pill will be seen as a silver bullet that makes condoms and other safer sex practices unnecessary.

Published
06 December 2012
From
RH Reality Check
PrEP
Controversial HIV study begins in Montreal

A team of researchers is seeking the help of up to 400 HIV-negative gay men to determine whether an antiretroviral drug could prevent the disease's spread by being ingested up to two hours before or up to a day after having sexual intercourse.

Published
02 December 2012
From
CBC.ca
PrEP
Manhunt Cares: PrEP

Manhunt informational pages on PrEP.

Published
01 December 2012
From
Manhunt
PrEP
Manhunt to Promote HIV Prevention Pill Truvada for World AIDS Day: 'A Choice When Condoms Are In The Way'

Manhunt™ will promote pre-exposure prophylaxis (PrEP) for this year's World AIDS Day. Manhunt is the world's largest online and mobile sexual networking site for gay men. The promotion is being sent to over 2.5 million Manhunt members on World AIDS Day through Manhunt’s internal email broadcast system with the following tagline: “HIV Prevention Pill for Negative Men (and women too): A choice when condoms are in the way or not enough?”

Published
01 December 2012
From
Towleroad
HIV prevention policy
AVAC: Achieving the End - One Year and Counting

With this year’s AVAC Report, we’re setting the clock on the global drive to end the AIDS epidemic. It’s a goal that nearly all now agree is attainable. But it can only be achieved if an ambitious pace of funding, implementation and research is set—and maintained—starting now.

Published
28 November 2012
From
AVAC
PrEP
Recreational drug use associated with non-prescription use of HIV PrEP among gay men in Australia

Recreational drug use is associated with the non-prescription use of HIV pre-exposure prophylaxis (PrEP) among gay men in Australia, according to research published in the online edition

Published
10 November 2012
By
Michael Carter
PrEP
(PrEP) The ANRS-IPERGAY study should be discontinued : prevention research in France is in disarray

French HIV prevention activist group The Warning has issued a press release saying that the placebo arm of the French IPERGAY randomised controlled study of intermittent PrEP should be dropped. This is in response to a 31 October press release by the French National HIV Research Agency, ANRS, that said it should continue - see http://public.adequatesystems.com/pub/link/203893/034296629555571351674647159-anrs.fr.html . The Warning's position does not reflect the position of other French community organisations, which take positions from support of the IPERGAY trial as it is, to demanding PrEP be made available alongside the trial, to total rejection of it. See http://www.ipergay.fr/Les-avis-des-comites-sur-la-poursuite-de-l-essai-Ipergay_a91.html for a sumary of community reports to the trial co-ordinators (in French).

Published
09 November 2012
From
The Warning
← Prev12345...24Next →

Filter by country